Advertisement

Featured in NEJM Journal Watch: Lack of Efficacy for Doxycycline in Stunting Aneurysm Growth — Physician’s First Watch

Medical News |
January 27, 2014

Featured in NEJM Journal Watch: Lack of Efficacy for Doxycycline in Stunting Aneurysm Growth

By the NEJM Journal Watch Editors

Contrary to evidence from preclinical studies, doxycycline failed to decrease growth of small abdominal aortic aneurysms in an aborted randomized trial in the Annals of Internal Medicine. Cardiologist Joel Gore writes in NEJM Journal Watch: "A medical treatment to retard abdominal aortic aneurysm enlargement and obviate or delay the need for surgical repair remains elusive."

Reader Comments (1)

zyrtec manufacturer Resident, Family Medicine/General Practice
Competing Interests: field_please_disclose[und][0][value]

A formidable share, I just given this onto a colleague who was doing slightly analysis on this. And he in fact purchased me breakfast because I discovered it for him.. smile. So let me reword that: Thnx for the treat! But yeah Thnkx for spending the time to discuss this, I feel strongly about it and love studying extra on this topic. If possible, as you turn into experience, would you thoughts updating your wephorum with more particulars? It's highly helpful for me. Huge thumb up for this wephorum publish! downside of claritin

Your Comment

(will not be published)

Filtered HTML

  • Allowed HTML tags: <a> <em> <strong> <cite> <blockquote> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Do you have any conflict of interest to disclose?
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
Image CAPTCHA
Enter the characters shown in the image.

Vertical Tabs

* Required

Reader comments are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

Advertisement
Advertisement
Advertisement